(CIM) Chimera Investment - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US16934Q2084
CIM: Mortgage Loans, Mortgage-Backed Securities, Real Estate Securities
Chimera Investment Corporation (NYSE:CIM) is a U.S.-based real estate investment trust (REIT) that specializes in mortgage-backed assets, operating at the intersection of real estate and fixed-income markets. Established in 2007 and headquartered in New York, the company has carved out a niche as a mortgage REIT, focusing on a diverse portfolio of mortgage-related securities and loans. Its strategy involves investing in both agency and non-agency residential mortgage-backed securities (RMBS), as well as commercial mortgage-backed securities (CMBS). Additionally, it holds business purpose and investor loans, which are increasingly important in today’s real estate market.
Chimera’s portfolio spans investment-grade, non-investment-grade, and non-rated securities, reflecting its willingness to take calculated risks in pursuit of higher yields. This approach allows the company to capitalize on opportunities across different segments of the mortgage market, from government-backed loans to more complex, private mortgage-backed securities. As a REIT, Chimera is required to distribute at least 90% of its taxable income to shareholders, making it an attractive option for income-focused investors.
With a market capitalization of approximately $1.14 billion, Chimera operates at a scale that allows it to navigate the complexities of the mortgage markets while maintaining a diversified portfolio. Its financial metrics, including a price-to-book (P/B) ratio of 0.45 and a trailing P/E of 12.90, suggest that the market is pricing in both the potential for future growth and the inherent risks of its asset classes. The forward P/E of 7.67 indicates expectations of improving earnings, while the price-to-sales (P/S) ratio of 4.13 reflects the company’s ability to generate revenue from its mortgage investments.
For investors and fund managers, Chimera offers exposure to the U.S. housing market and the broader mortgage finance ecosystem. Its focus on both agency and non-agency securities provides a balance between stability and potential upside, though it also introduces risks tied to interest rate fluctuations, credit performance, and regulatory changes. As with any mortgage REIT, understanding the interplay between interest rates, housing market dynamics, and the company’s leverage is critical for evaluating its long-term prospects.
Additional Sources for CIM Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CIM Stock Overview
Market Cap in USD | 1,060m |
Sector | Real Estate |
Industry | REIT - Mortgage |
GiC Sub-Industry | Mortgage REITs |
IPO / Inception | 2007-11-16 |
CIM Stock Ratings
Growth 5y | -11.7% |
Fundamental | 19.7% |
Dividend | 39.7% |
Rel. Strength | -10.9 |
Analysts | 3/5 |
Fair Price Momentum | 13.17 USD |
Fair Price DCF | 22.84 USD |
CIM Dividends
Dividend Yield 12m | 13.53% |
Yield on Cost 5y | 13.08% |
Annual Growth 5y | -19.50% |
Payout Consistency | 78.8% |
CIM Growth Ratios
Growth Correlation 3m | -70% |
Growth Correlation 12m | 45.8% |
Growth Correlation 5y | -59.8% |
CAGR 5y | -1.35% |
CAGR/Max DD 5y | -0.02 |
Sharpe Ratio 12m | -0.13 |
Alpha | -6.78 |
Beta | 1.847 |
Volatility | 30.09% |
Current Volume | 620.6k |
Average Volume 20d | 531.4k |
As of April 03, 2025, the stock is trading at USD 12.79 with a total of 620,622 shares traded.
Over the past week, the price has changed by -0.44%, over one month by -7.05%, over three months by -6.46% and over the past year by +8.98%.
Neither. Based on ValueRay Fundamental Analyses, Chimera Investment is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 19.69 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CIM as of April 2025 is 13.17. This means that CIM is currently overvalued and has a potential downside of 2.97%.
Chimera Investment has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold CIM.
- Strong Buy: 0
- Buy: 0
- Hold: 5
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, CIM Chimera Investment will be worth about 14.2 in April 2026. The stock is currently trading at 12.79. This means that the stock has a potential upside of +11.26%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 15.8 | 23.1% |
Analysts Target Price | 15.8 | 23.1% |
ValueRay Target Price | 14.2 | 11.3% |